PharmaCyte Biotech PMCB Insider Ownership

NASDAQ PMCB
$0.48 -0.01 (-2.68%)
As of: Sep 9, 2026 · 3:59 PM EDT

Insider Holdings by Owner

608.75K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
8.96%
0% pp QoQ
Shares Held by Insiders
608.75K
filed for Sep 2026
0.00% QoQ
Shares Outstanding
6.80Mn
6,795,779 shares
Direct Holdings
608.75K
Indirect: 0
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
2
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

PMCB's three largest insider shareholders as of September 09, 2026 are Joshua Silverman (Ceo And President, 416.25K shares), Jonathan Schechter (Director, 192.50K shares).

Form 4 Holdings

Insiders Holding PMCB

Insiders 2
Shares held 608.75K
Of outstanding 8.96%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Joshua Silverman Ceo And President 416,250 0 416,250 68.4% 07 Jan, 2026
2 Jonathan Schechter Director 192,500 0 192,500 31.6% 07 Jan, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

19 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
31 Mar, 2026 Jonathan Schechter Director Acquired A 119,170 $0.00 $0 119,170 Direct
31 Mar, 2026 Michael M Abecassis Director Acquired A 119,170 $0.00 $0 119,170 Direct
31 Mar, 2026 Robert Weinstein Director Acquired A 119,170 $0.00 $0 119,170 Direct
05 Jan, 2026 Jonathan Schechter Director Acquired P 20,000 $0.78 $15.55K 152,500 Direct
05 Jan, 2026 Joshua Silverman Ceo And President Acquired P 30,000 $0.78 $23.49K 346,250 Direct
06 Jan, 2026 Joshua Silverman Ceo And President Acquired P 30,000 $0.79 $23.67K 376,250 Direct
06 Jan, 2026 Jonathan Schechter Director Acquired P 20,000 $0.79 $15.81K 172,500 Direct
07 Jan, 2026 Jonathan Schechter Director Acquired P 20,000 $0.84 $16.87K 192,500 Direct
07 Jan, 2026 Joshua Silverman Ceo And President Acquired P 40,000 $0.83 $33.32K 416,250 Direct
12 Dec, 2025 Joshua Silverman Ceo And President Acquired A 575,000 $0.00 $0 575,000 Direct
12 Dec, 2025 Joshua Silverman Ceo And President Disposed F 258,750 $1.02 $263.93K 316,250 Direct
20 Nov, 2023 Joshua Silverman Interim Ceo, Interim President Acquired A 170,000 $0.00 $0 170,000 Direct
20 Nov, 2023 Michael M Abecassis Director Acquired A 61,248 $0.00 $0 61,248 Direct
20 Nov, 2023 Carlos Trujillo Chief Financial Officer Acquired A 85,000 $0.00 $0 85,000 Direct
20 Nov, 2023 Carlos Trujillo Chief Financial Officer Acquired A 85,000 $0.00 $0 85,000 Direct
20 Nov, 2023 Jonathan Schechter Director Acquired A 61,248 $0.00 $0 61,248 Direct
20 Nov, 2023 Robert Weinstein Director Acquired A 61,248 $0.00 $0 61,248 Direct
28 Dec, 2022 Daniel Allen Director Acquired A 125,000 $0.00 $0 125,000 Direct
28 Dec, 2022 Daniel Stuart Farb Director Acquired A 125,000 $0.00 $0 125,000 Direct